Company profile
Congruence Therapeutics
From Topology to Treatments.
- Industry
- Biotechnology Research
- Employees
- 44
- Headquarters
- Montreal, Quebec
- Founded
- 2021
- LinkedIn followers
- 6,672
- Office locations
- 1
Congruence Therapeutics company summary
Congruence Therapeutics is a company in the Biotechnology Research industry, headquartered in Montreal, Quebec, founded in 2021. On LinkedIn the company has around 44 employees and 6,672 followers. Warmrank detected 25 technologies across 19 categories on congruencetx.com, including Akismet, Apple iCloud Mail, Barracuda Email Security. Its listed specialties include biotechnology, computational chemistry, machine learning, protein misfolding.
What technology does Congruence Therapeutics use?
Warmrank detected 25 technologies on congruencetx.com, last checked July 2026. Click any tool to see other companies that use it.
JavaScript libraries
Font scripts
Miscellaneous
WordPress plugins
CMS
Databases
Hosting
JavaScript frameworks
PaaS
Performance
Programming languages
Security
SSL/TLS certificate authorities
Video players
Web servers
Show 1 more technologiesShow fewer technologies
Widgets
About Congruence Therapeutics
Congruence is a computationally-driven biotechnology company building a unique pipeline of transformative small molecule correctors rationally designed to rescue aberrant protein function. Our proprietary scalable platform, Revenir™, captures the biophysical features of proteins across their conformational ensembles, in order to identify novel allosteric and cryptic pockets which are virtually screened to generate novel chemical matter.
Specialties
Where is Congruence Therapeutics located?
Congruence Therapeutics lists 1 location.
Compare companies similar to Congruence Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Congruence Therapeutics congruencetx.com | Biotechnology Research | 44 | 2021 | Montreal, Quebec |
Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Congruence Therapeutics
What does Congruence Therapeutics do?
Congruence is a computationally-driven biotechnology company building a unique pipeline of transformative small molecule correctors rationally designed to rescue aberrant protein function. Our proprietary scalable platform, Revenir™, captures the biophysical features of proteins across their conformational ensembles, in order to identify novel allosteric and cryptic pockets which are virtually screened to generate novel chemical matter.
What technology does Congruence Therapeutics use?
Warmrank detected 25 technologies on congruencetx.com, including Akismet, Apple iCloud Mail, Barracuda Email Security, Font Awesome, GSAP, GoDaddy, Google Font API, Google Hosted Libraries.
How many employees does Congruence Therapeutics have?
Congruence Therapeutics has around 44 employees on LinkedIn.
Where is Congruence Therapeutics headquartered?
Congruence Therapeutics is headquartered in Montreal, Quebec.
When was Congruence Therapeutics founded?
Congruence Therapeutics was founded in 2021.
Build a lead list from companies like Congruence Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.